Nektar Therapeutics (NKTR) Gross profit 2016–2025
Nektar Therapeutics (NKTR) annual gross profit history from SEC filings — each fiscal year as reported.
$55.2MFY2025 · since FY2016: $135.2M → $55.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $55.2M | -18.5% |
| FY2024 | $67.7M | +20.2% |
| FY2023 | $56.4M | -20.0% |
| FY2022 | $70.4M | -8.6% |
| FY2021 | $77.0M | -42.3% |
| FY2020 | $133.4M | +43.1% |
| FY2019 | $93.2M | -92.0% |
| FY2018 | $1.2B | +321.7% |
| FY2017 | $277.2M | +105.0% |
| FY2016 | $135.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice